Bionik Laboratories Corp.
BNKLOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1248
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Bionik Laboratories Corp. (BNKL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BNKL · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-03 | 2022-03 | 2021-03 | 2020-03 | 2019-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.81M | $1.27M | $1.19M | $2.15M | $3.25M |
| Cost of Revenue | $0.82M | $0.32M | $0.27M | $0.89M | $1.63M |
| Gross Profit | $0.99M | $0.95M | $0.92M | $1.26M | $1.62M |
| Gross Margin %(computed) | 54.83% | 74.84% | 77.41% | 58.51% | 49.78% |
| Operating Expenses | |||||
| R&D Expenses | $0.90M | $1.00M | $1.49M | $3.89M | $3.17M |
| G&A Expenses | $2.93M | $2.81M | $4.57M | $5.98M | $5.24M |
| Total Operating Expenses | $5.81M | $5.73M | $7.08M | $12.42M | $11.10M |
| Operating Income | ($4.83M) | ($4.77M) | ($6.16M) | ($11.25M) | ($7.29M) |
| Operating Margin %(computed) | -267.29% | -374.70% | -515.76% | -522.25% | -224.59% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.11M | $0.83M | $0.41M | $0.18M | $3.27M |
| Income Before Tax | ($4.95M) | ($10.41M) | ($13.62M) | ($25.02M) | ($10.56M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | ($0.00M) |
| Net Income | ($4.95M) | ($10.41M) | ($13.62M) | ($24.93M) | ($10.56M) |
| Net Margin %(computed) | -273.99% | -817.14% | — | — | -325.20% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.72 | $-1.78 | $-2.66 | $-5.60 | $-4.47 |
| Wtd Avg Shares | 6.90M | 5.84M | 5.13M | 4.46M | 2.36M |
| EBITDA | ($4.78M) | ($9.48M) | ($13.03M) | ($24.45M) | ($6.94M) |
| EBITDA Margin %(computed) | -264.55% | -744.29% | — | — | -213.84% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Bionik Laboratories Corp. data
About Bionik Laboratories Corp. (BNKL) Income Statement
Bionik Laboratories Corp. (BNKL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, BNKL reported revenue of $0.00B, gross profit of $0.00B (gross margin 54.83%), and net income of ($0.00B) — a net profit margin of -273.99%.
Frequently asked questions
BNKL · 4 questionsBionik Laboratories Corp. (BNKL) reported revenue of $0.00B for 2023, up 41.7% year-over-year.
BNKL revenueBNKL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08